Zhejiang Xianju Pharmaceutical Co.,Ltd. (SHE:002332)
China flag China · Delayed Price · Currency is CNY
8.81
+0.04 (0.46%)
Apr 29, 2026, 3:04 PM CST

SHE:002332 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
1,2161,1961,3821,6601,7201,267
Trading Asset Securities
-----500.64
Cash & Short-Term Investments
1,2161,1961,3821,6601,7201,768
Cash Growth
-10.76%-13.45%-16.76%-3.51%-2.67%-8.79%
Accounts Receivable
1,1551,051856.66726.38706.37752.24
Other Receivables
25.3189.2245.8615.4170.8417.66
Receivables
1,1801,141902.52741.79777.21769.9
Inventory
895.74914.38930.86922.88890.5910.7
Other Current Assets
63.0251.6248.4575.1646.11127.64
Total Current Assets
3,3553,3033,2643,4003,4343,576
Property, Plant & Equipment
2,8122,8202,5492,2572,0381,997
Long-Term Investments
274.12280.34303.56280.92278.26280.21
Goodwill
614.37636.02581.21606.96573.27557.57
Other Intangible Assets
144.15150.19151.07166.49177.18178.4
Long-Term Deferred Tax Assets
34.3732.8528.7621.6228.6125.39
Long-Term Deferred Charges
16.9416.5411.210.1610.1912.55
Other Long-Term Assets
14.4619.87110.78249.99197.84101.12
Total Assets
7,2657,2597,0006,9936,7386,728
Accounts Payable
338.15303.72309.11484.51354.78385.31
Accrued Expenses
96.23109.05132.12127.86124.54175.4
Short-Term Debt
114.6156.338.511.0337.465.59
Current Portion of Long-Term Debt
17.430.8514.75166.36102.4346.8
Current Portion of Leases
--4.923.476.376.22
Current Income Taxes Payable
64.380.4523.391128.4321.94
Current Unearned Revenue
23.1827.3230.6231.6846.8941.9
Other Current Liabilities
356.25341.26254.67221.01268.26346.94
Total Current Liabilities
1,0101,049778.091,047969.071,390
Long-Term Debt
12.159.0920.438.74193.85313.14
Long-Term Leases
4.295.1410.389.754.47.49
Long-Term Unearned Revenue
105.84102.6697.2557.8654.5359.28
Long-Term Deferred Tax Liabilities
----0.23-
Other Long-Term Liabilities
10.410.89205.299.538.498.31
Total Liabilities
1,1431,1771,1111,1631,2311,778
Common Stock
989.2989.2989.2989.2989.2989.2
Additional Paid-In Capital
1,8521,8521,8411,8201,8031,802
Retained Earnings
3,1743,0803,0272,9262,6602,059
Comprehensive Income & Other
63.49113.58-13.5250.615.74-15.98
Total Common Equity
6,0796,0355,8445,7865,4574,834
Minority Interest
43.4646.9844.6743.9250.01115.66
Shareholders' Equity
6,1226,0825,8885,8305,5074,950
Total Liabilities & Equity
7,2657,2597,0006,9936,7386,728
Total Debt
148.43201.4158.95219.36344.42739.25
Net Cash (Debt)
1,068994.641,3231,4411,3761,028
Net Cash Growth
-17.84%-24.82%-8.17%4.70%33.81%35.35%
Net Cash Per Share
1.071.001.331.461.391.04
Filing Date Shares Outstanding
989.321,029989.2989.2989.2989.2
Total Common Shares Outstanding
989.321,029989.2989.2989.2989.2
Working Capital
2,3452,2542,4862,3532,4652,186
Book Value Per Share
6.145.865.915.855.524.89
Tangible Book Value
5,3205,2495,1115,0134,7074,098
Tangible Book Value Per Share
5.385.105.175.074.764.14
Buildings
--1,1541,112977.171,025
Machinery
--2,0251,803275.361,506
Construction In Progress
--714.85522.17374.2367.9
Source: S&P Global Market Intelligence. Standard template. Financial Sources.